Tag: CRISPR Therapeutics AG

Opinion: Biotech stocks are a buy — especially these 18 picks

There’s a world of hurt in biotech. It’s in a bear market. The good news is the pullback offers an chance to get into exciting areas of biotech research like gene editing and oncology at better prices. Some of these names will see buyout pops since they’re now more attractive targets for big pharmaceutical firms. […]

Read More

Cathie Wood called this one of her most underappreciated stocks. Its CEO explains its growth story

Shares of Invitae rose over 25% this week, a sharp move higher that came after Ark Invest’s Cathie Wood called the company one of her most underappreciated stocks in a CNBC interview on Monday. Invitae was the 11th-largest holding in Wood’s flagship fund, the Ark Innovation ETF (ARKK), as of Thursday, giving it a weighting larger […]

Read More